• Ziprasidone Hydrochloride (A5350): Mechanisms, Benchmarks...

  2026-03-26

  Ziprasidone Hydrochloride (Ziprasidone HCl) is a validated serotonin and dopamine receptor antagonist with anti-psychotic and emerging antitumor properties. Its dual mechanism—high affinity for 5-HT2A/D2 and GOT1 inhibition—enables advanced neuroscience and cancer research models. This article aggregates citable facts, experimental benchmarks, and structured workflows for laboratory and translational applications.

• Ziprasidone Hydrochloride: Integrative Mechanisms and Eme...

  2026-03-25

  Explore the multifaceted potential of Ziprasidone Hydrochloride as a serotonin and dopamine receptor antagonist and GOT1 inhibitor. This in-depth review uncovers advanced mechanistic insights and translational applications in neuroscience and pancreatic cancer research, providing a unique perspective beyond standard methodologies.

• Ziprasidone HCl: Applied Oncology & Neuroscience Research...

  2026-03-25

  Ziprasidone Hydrochloride (Ziprasidone HCl) is a second-generation antipsychotic that uniquely bridges neuroscience and oncology, offering dual action as a serotonin and dopamine receptor antagonist and a GOT1 inhibitor. This guide delivers stepwise experimental workflows, advanced troubleshooting, and protocol enhancements to empower high-fidelity dopaminergic and oncologic research with APExBIO's trusted reagent.

• Ziprasidone Hydrochloride: Innovative GOT1 Inhibition and...

  2026-03-24

  Explore the unique role of Ziprasidone Hydrochloride as a GOT1 inhibitor in disrupting tumor redox balance and glutamine metabolism. This article offers advanced insights into its application for pancreatic cancer research and its mechanistic advantages over traditional antipsychotic and oncology agents.

• Ziprasidone Hydrochloride: Dual GOT1 Inhibitor & Dopamine...

  2026-03-24

  Ziprasidone Hydrochloride (Ziprasidone HCl) is a second-generation antipsychotic and verified GOT1 inhibitor with quantitative antitumor and neuroscience research benchmarks. This dossier details its dual action on dopaminergic and serotonergic pathways, precise in vitro and in vivo parameters, and robust safety profile, supporting advanced research applications.

• Optimizing Cell Assays with Ziprasidone Hydrochloride (SK...

  2026-03-23

  This article provides scenario-driven, scientifically validated guidance for leveraging Ziprasidone Hydrochloride (SKU A5350) in cell viability, proliferation, and cytotoxicity assays. By addressing common laboratory challenges with practical solutions, we demonstrate how this serotonin and dopamine receptor antagonist supports reproducible and quantitative data in both neuroscience and cancer research. Discover how APExBIO’s high-purity formulation optimizes workflow reliability and experimental outcomes.

• Ziprasidone Hydrochloride: Redefining Translational Resea...

  2026-03-23

  This thought-leadership article examines Ziprasidone Hydrochloride (Ziprasidone HCl, SKU A5350) as a paradigm-shifting tool for translational researchers, uniquely leveraging its dual mechanistic roles as a serotonin/dopamine receptor antagonist and a GOT1 inhibitor. We dissect underlying biology, validate experimental models, survey the competitive landscape, and forecast clinical and translational trajectories. Drawing on the latest findings—including advancements in nanocrystal formulation for enhanced bioavailability—this piece guides researchers in maximizing Ziprasidone Hydrochloride's impact for neuroscience and oncology research, anchored by the quality and reliability of APExBIO’s offering.

• Ziprasidone HCl in Neuroscience and Oncology Research Wor...

  2026-03-22

  Ziprasidone Hydrochloride (Ziprasidone HCl) stands out as a dual-action serotonin and dopamine receptor antagonist with validated GOT1 inhibitory activity, enabling advanced research in both neuroscience and cancer biology. This guide details bench-proven workflows, permeability enhancements, and troubleshooting strategies to maximize reproducibility and translational value.

• Ziprasidone Hydrochloride: Mechanistic Advances in Antips...

  2026-03-21

  Explore the dual-action potential of Ziprasidone Hydrochloride as a serotonin and dopamine receptor antagonist and GOT1 inhibitor. This article uncovers its unique mechanisms, advanced bioavailability strategies, and distinct roles in neuroscience and cancer research.

• Ziprasidone Hydrochloride: Bridging Dopaminergic Signalin...

  2026-03-20

  Ziprasidone Hydrochloride (Ziprasidone HCl) is emerging as a transformative tool for translational researchers at the intersection of neuroscience and oncology. As a second-generation antipsychotic, Ziprasidone HCl is well-validated as a serotonin and dopamine receptor antagonist for schizophrenia research and psychotic disorder models. Recent breakthroughs, however, have revealed its novel role as a potent GOT1 inhibitor, disrupting glutamine metabolism and suppressing pancreatic cancer cell proliferation. This thought-leadership article integrates mechanistic evidence, experimental validation, and strategic guidance—empowering researchers to exploit Ziprasidone Hydrochloride from APExBIO for dual-application studies in both neural and cancer biology. By expanding beyond conventional product overviews, we provide a visionary framework for harnessing this compound’s full translational potential.

• Ziprasidone Hydrochloride (A5350): Reliable Solutions for...

  2026-03-20

  This article provides evidence-based guidance for biomedical researchers and lab technicians seeking reproducible results in cell viability, proliferation, and cytotoxicity assays using Ziprasidone Hydrochloride (SKU A5350). Drawing on validated performance metrics and best practices, it addresses common workflow challenges and positions Ziprasidone Hydrochloride as a robust tool for both cancer metabolism and neurotransmitter pathway research.

• Ziprasidone Hydrochloride: Redefining Antipsychotic and O...

  2026-03-19

  Explore the multifaceted applications of Ziprasidone Hydrochloride in neuroscience and cancer research. This in-depth review reveals novel mechanisms, including GOT1 inhibition and redox balance disruption, setting a new benchmark for atypical antipsychotic research.

• Ziprasidone Hydrochloride: Dual GOT1 Inhibitor and Seroto...

  2026-03-19

  Ziprasidone Hydrochloride (Ziprasidone HCl) is a second-generation antipsychotic agent that acts as both a serotonin and dopamine receptor antagonist and a non-competitive inhibitor of GOT1, enabling advanced research in neuroscience and cancer metabolism. Robust quantitative data benchmark its efficacy in inhibiting pancreatic cancer cell proliferation and modulating neurotransmitter pathways.

• Ziprasidone Hydrochloride (A5350): Mechanisms and Benchma...

  2026-03-18

  Ziprasidone Hydrochloride (Ziprasidone HCl) is a second-generation antipsychotic that functions as a serotonin and dopamine receptor antagonist with additional activity as a GOT1 inhibitor. It is widely used in both neuroscience and cancer research, offering robust, quantifiable outcomes for cell viability and proliferation assays.

• Ziprasidone Hydrochloride in Translational Research: Brid...

  2026-03-18

  Ziprasidone Hydrochloride (Ziprasidone HCl) stands at the crossroads of neuroscience and oncology, offering a rare convergence of validated serotonin/dopamine receptor antagonism and GOT1-mediated tumor metabolism disruption. This thought-leadership article synthesizes mechanistic insights and strategic guidance for translational researchers, drawing from recent advances in formulation science, quantitative benchmarks, and emerging clinical aspirations. By integrating evidence from advanced solid dispersion technology and competitive research, we chart a visionary path for leveraging Ziprasidone Hydrochloride (APExBIO, SKU A5350) in both psychopharmacology and cancer models.

444 records 23/30 page Previous Next First page 上5页 2122232425 下5页 Last page